Efficacy and safety of tofacitinib in the treatment of refractory cases of polyarticular course juvenile idiopathic arthritis: A study from Bangladesh

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

(2021) Nicolino Ruperto et al.   LANCET

Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis

(2019) Zhixiang Huang et al.   PEDIATRICS

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis

(2019) Sarah Ringold et al.   ARTHRITIS CARE & RESEARCH

Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis

(2018) Zhan-Guo Li et al.   CHINESE MEDICAL JOURNAL

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study

(2017) Nicolino Ruperto et al.   Pediatric Rheumatology

Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India

(2016) Nisha Vengassery Balakrishnan Menon et al.   International Journal of Rheumatic Diseases

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score

(2013) Alessandro Consolaro et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence and clinical pattern of juvenile idiopathic arthritis in a semi-urban area of Bangladesh

(2012) Shaiful Azam et al.   International Journal of Rheumatic Diseases

The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon

(2011) Sanna Rosengren et al.   ANNALS OF THE RHEUMATIC DISEASES

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells

(2011) Keisuke Maeshima et al.   ARTHRITIS AND RHEUMATISM

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

(2011) Kamran Ghoreschi et al.   JOURNAL OF IMMUNOLOGY

Development and validation of a composite disease activity score for juvenile idiopathic arthritis

(2009) Alessandro Consolaro et al.   ARTHRITIS AND RHEUMATISM

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

(2008) Nicolino Ruperto et al.   LANCET